Nektar Therapeutics
0 sources
Financials
0001193125-26-104547Nektar Therapeutics
Summary
Nektar Therapeutics is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (95 views/month).[2]
Key Facts
- Nektar Therapeutics is in the country of United States[3].
- Nektar Therapeutics is in the country of US[4].
- Nektar Therapeutics's instance of is recorded as business[5].
- Nektar Therapeutics's instance of is recorded as public company[6].
- Nektar Therapeutics's headquarters location is recorded as San Francisco[7].
- Nektar Therapeutics's stock exchange is recorded as Nasdaq[8].
- 1990 marks the founding of Nektar Therapeutics[9].
- Nektar Therapeutics's official website is recorded as http://www.nektar.com/[10].
- Nektar Therapeutics's product or material produced is recorded as Inhalable insulin[11].
- Nektar Therapeutics's legal form is recorded as 8888[12].
Body
Founding
1990 marks the founding of Nektar Therapeutics[9].
Operations
Nektar Therapeutics's headquarters location is recorded as San Francisco[7].
Ownership
Nektar Therapeutics's stock exchange is recorded as Nasdaq[8]. Its product or material produced is recorded as Inhalable insulin[11].
Why It Matters
Nektar Therapeutics ranks in the top 4% of business entities by monthly Wikipedia readership (95 views/month).[2] It is known by 4 alternative names across languages and contexts.[13]